A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
Table 3
Tumor zygosity predictions of somatic mutations in 20,182 clinical samples.
Tumor zygosity predictions of somatic mutations in 20,182 clinical samples.